During the past decade, Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum" #1 collaborator was "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "SOLTI Breast Cancer Research Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum" are "Breast Cancer" (2 trials) and "Triple-negative Breast Cancer" (1 trials). Many other conditions were trialed in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum" in a lesser frequency.

Most popular intervention types in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Cyclophosphamide" (1 trials), "Doxorubicin" (1 trials) and "Filgrastim" (1 trials). Other intervention names were less common.

The vast majority of trials in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Evangelische Kliniken Gelsenkirchen GmbH; Brustzentrum, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".